4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-016043
See Remarks sold 389 shares at $45.65 ($17,758)
- See Remarks returned 10,599 shares (to the company)
- See Remarks acquired 24,663 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huang Dennis Karl See Remarks | 2023-03-01 | Grant or award | +2,663 | 53,703 | D: show line 1 in the form | ||
| Huang Dennis Karl See Remarks | 2023-03-01 | Grant or award | +22,000 | 75,703 | D: show line 2 in the form | ||
| Huang Dennis Karl See Remarks | 2023-03-01 | Sale | −389 | $45.65 | $17,758 | 75,314 | D: show line 3 in the form |
| Huang Dennis Karl See Remarks | 2023-03-01 | Returned to the company | −10,599 | $45.65 | $483,844 | 64,715 | D: show line 4 in the form |
| Open-market sales · 389 sh · avg $45.65 · $17,758 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Huang Dennis Karl See Remarks | 2023-03-01 | Grant or award · Stock Option (Right to Buy) | +39,400 | 39,400 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…